Warning letter
Merge Healthcare, Inc.: warning letter of Sep 30, 2015
FDA warning letter 480372 · Minneapolis District Office
Key facts
| Reference number | 480372 |
|---|---|
| Company | Merge Healthcare, Inc. |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Sep 30, 2015 |
| Posted date | Oct 13, 2015 |
| Issuing office | Minneapolis District Office |
| Product type | Devices |
| CFR sections cited | 806, 806.10, 820 |
| Inspection city | Hartland |
| Inspection ZIP | 53029 |
| Inspection start date | Jun 3, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: